{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:29:12Z","timestamp":1773325752219,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bpobgyn.2026.102702","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:43:59Z","timestamp":1768711439000},"page":"102702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnosis and treatment of PCOS in adolescents: a summary of guidelines and systematic reviews for practitioners"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-8900","authenticated-orcid":false,"given":"Tania","family":"Dumont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdelena","family":"Peeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"El Masri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102702_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 international evidence-based Guideline for the assessment and management of polycystic ovary syndrome","volume":"38","author":"Teede","year":"2023","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-025-03901-w","article-title":"International evidence-based recommendations for polycystic ovary syndrome in adolescents","volume":"23","author":"Pe\u00f1a","year":"2025","journal-title":"BMC Med"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2147\/IJWH.S506498","article-title":"Diagnosis and treatment of adolescent polycystic ovary syndrome: a review","volume":"17","author":"Zhang","year":"2025","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102702_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current Guidelines for diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.bpobgyn.2026.102702_bib10","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society Clinical Practice Guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102702_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1430","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"136","author":"Rosenfield","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","article-title":"Adolescent polycystic ovary syndrome according to the international evidence-based guideline","volume":"18","author":"Pe\u00f1a","year":"2020","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102702_bib4","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102702_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/humrep\/deae042","article-title":"Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline","volume":"39","author":"Kim","year":"2024","journal-title":"Hum Reprod (Oxf)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jog.16152","article-title":"Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria","volume":"51","author":"Noguchi","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102702_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.xfre.2022.01.008","article-title":"Ovarian follicle count by magnetic resonance imaging is greater in adolescents and young adults with polycystic ovary syndrome than in controls","volume":"3","author":"Pereira-Eshraghi","year":"2022","journal-title":"F and S Reports"},{"issue":"12","key":"10.1016\/j.bpobgyn.2026.102702_bib13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s12519-024-00857-4","article-title":"What can we do for the adolescents with polycystic ovary syndrome?","volume":"20","author":"Chen","year":"2024","journal-title":"World J Pediatr"},{"issue":"0","key":"10.1016\/j.bpobgyn.2026.102702_bib14","article-title":"Effects OF COMBINED hormonal contraceptives (CHC) ON bone health in adolescent girls \u2013 a systematic review","volume":"0","author":"Lim","year":"2025","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102702_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2009.11.001","article-title":"Low-dose oral contraceptives in adolescents: how low can you go?","volume":"23","author":"Agostino","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/jcm12031221","article-title":"PCOS in adolescents\u2014Ongoing riddles in diagnosis and treatment","volume":"12","author":"Meczekalski","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/jcm12010067","article-title":"Non-Hormonal treatment options for regulation of menstrual cycle in adolescents with PCOS","volume":"12","author":"Reiser","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102702_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/jpem-2023-0458","article-title":"Myoinositol or D-chiro-inositol for PCOS symptoms in adolescents: a narrative review","volume":"37","author":"Sairally","year":"2024","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102702_bib19","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.jogc.2018.03.007","article-title":"No. 292-Abnormal uterine bleeding in pre-menopausal women","volume":"40","author":"Singh","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s12519-024-00857-4","article-title":"What can we do for the adolescents with polycystic ovary syndrome? Challenges in diagnosing PCOS in adolescents. 0123456789)","volume":"20","author":"Chen","year":"2024","journal-title":"World Journal of Pediatrics"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102702_bib22","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2013.09.010","article-title":"Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study","volume":"27","author":"Tartagni","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102702_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib25","series-title":"Current medical research and opinion human dermal safety studies with eflornithine HCl 13.9% cream (VaniqaTM), a novel treatment for excessive facial hair","author":"Hickman","year":"2000"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib28","series-title":"PRODUCT MONOGRAPH VANIQA \u00ae (Eflornithine Hydrochloride) cream 13.9 %","year":"2015"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102702_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00000441-200512000-00012","article-title":"Polycystic ovarian syndrome and the metabolic syndrome","volume":"330","author":"Sartor","year":"2005","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s43032-022-00864-8","article-title":"The Association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and meta-analysis","volume":"30","author":"Fu","year":"2022","journal-title":"Reprod Sci"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102702_bib35","first-page":"3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ib\u00e1\u00f1ez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.bpobgyn.2026.102702_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102702_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-5448.2012.00902.x","article-title":"Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI","volume":"14","author":"Flannery","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102702_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2011.12.002","article-title":"Dyslipidemia in PCOS","volume":"77","author":"Wild","year":"2012","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102702_bib42","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s43032-022-00864-8","article-title":"The Association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and meta-analysis","volume":"30","author":"Fu","year":"2022","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib44","first-page":"970","article-title":"Impaired ApoB-Lipoprotein and triglyceride metabolism in obese adolescents with polycystic ovary syndrome","volume":"102","author":"Vine","year":"2017","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102702_bib46","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): Comparison between nonobese and Obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102702_bib51","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.sleep.2012.07.002","article-title":"Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome","volume":"13","author":"Nandalike","year":"2012","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102702_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pedn.2010.08.001","article-title":"Emotional needs of teens with polycystic ovary syndrome","volume":"27","author":"Dowdy","year":"2012","journal-title":"J Pediatr Nurs [Internet]"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102702_bib48","first-page":"399","article-title":"Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome","volume":"92","author":"Zachurzok","year":"2021","journal-title":"Ginekol Pol [Internet]"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib49","article-title":"Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102702_bib50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2024.01.018","article-title":"Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms","volume":"121","author":"Alur-Gupta","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib29","article-title":"Myo-Inositol in the treatment of teenagers affected by PCOS","volume":"2016","author":"Pkhaladze","year":"2016","journal-title":"Internet J Endocrinol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2026.102702_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/09513590.2020.1725967","article-title":"HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)","volume":"36","author":"Cirillo","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2026.102702_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1436952","article-title":"Treatment and complications of PCOS in adolescents - what's new in 2023?","volume":"15","author":"Jakubowska-Kowal","year":"2024","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102702_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpag.2014.05.005","article-title":"The effect of chromium supplementation on polycystic ovary syndrome in adolescents","volume":"28","author":"Amr","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693426000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693426000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:30:01Z","timestamp":1773275401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693426000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S1521693426000027"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2026.102702","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of PCOS in adolescents: a summary of guidelines and systematic reviews for practitioners","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2026.102702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102702"}}